index.html

Bend Biomedical is a 501(c)(3) nonprofit global health pharmaceutical company. We deliver high-quality, low-cost medicines to prevent and cure serious diseases in neglected populations around the world.

Bend Biomedical has three complementary aims: (1) identify and address shortages of essential global-health pharmaceuticals, particularly medicines for serious preventable and curable diseases affecting neglected populations; (2) develop and provide affordable, standardized field medical kits for emergency and primary care, including midwifery, containing essential medicines, supplies, diagnostics, and equipment needed to provide basic care in resource-limited settings; and (3) develop health informatics systems that track the availability, location, demand, and treatment gaps of essential medicines, medical supplies, and field medical kits, allowing governments, NGOs, manufacturers, and health workers to identify shortages and direct resources to where they are most urgently needed. Together, these aims seek to ensure that essential medicines and basic medical resources are available where and when they are needed most.Medicines and Target Diseases

To qualify to be one of our list of medicines, All Bend Biomedical target diseases must be highly prevalent and preventable or curable. These medications face global supply shortages, meaning there isn’t enough reaching the people who need them most.

Bend Biomedical focuses on preventable or curable diseases that cause a substantial burden of illness or death in underserved populations and for which access to effective treatment remains inadequate.

We prioritize medicines where Bend Biomedical can help close a meaningful gap in global treatment access. Our target medicines fall into two categories:

Treatment Gap Medicines

Medicines already manufactured and donated at scale by pharmaceutical companies, but for which significant treatment gaps remain because existing donations do not reach everyone who needs treatment.

● Albendazole

● Azithromycin

● Diethylcarbamazine

● Ivermectin

● Praziquantel

Neglected Need Medicines

Medicines for serious diseases or populations for which commercial incentives are insufficient to ensure adequate availability, affordability, formulation, or supply.

● Benzathine Penicillin

● Benznidazole

● Iron, Folic Acid, Vitamin B6, Vitamin B12, Vitamin D & Zinc

● Oral Rehydration Solution

● Vitamin A

Our Selection Criteria

Bend Biomedical prioritizes medicines that can make a large, measurable difference in global health, particularly when:

● The disease is preventable or curable.

● The disease affects large numbers of people, particularly children and other vulnerable populations.

● Effective medicines already exist but access remains inadequate.

● There is a significant treatment, supply, affordability, formulation, or distribution gap.

● Bend Biomedical can provide a meaningful solution through manufacturing, packaging, procurement, or distribution.

Our medicines fit into three categories

1. Extremely dose-efficient — one-time treatment

2. Periodic mass prevention

3. Longer courses

We do not require every target disease to meet a single numerical threshold, such as a minimum number of cases per year. Instead, we consider the overall burden of illness, disability, and death; the availability of effective prevention or treatment; the severity of existing access gaps; and Bend Biomedical’s ability to make a meaningful, measurable contribution.

Target Diseases

Yaws

Vitamin A Deficiency

Under-Five Mortality

Neural Tube Defects

Oral Clefts

Diarrhea

Congenital Syphilis

Chagas Disease

Onchocerciasis

Female Genital Schistosomiasis

Lymphatic Filariasis

Scabies

Soil-Transmitted Helminths